Brainstorm Cell Therapeutics Inc. (BCLI)
Operating Cash Flow Growth
57.20%
TTM · Period ending:
BCLI Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported57.20%period ending
Latest reported57.20%period ending
BCLI TTM Cash from Operations YoY % (-120.14% → 57.20%)
Year-over-year change
High-resolution chart · PNG
BCLI operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 57.2046% | |
| 13.014% | |
| 23.2926% | |
| 35.7193% | |
| 34.349% | |
| 60.7832% | |
| 55.5528% | |
| 48.0775% | |
| 28.7336% | |
| 0.4231% | |
| -5.8903% | |
| -8.1318% | |
| 7.0124% | |
| 6.5142% | |
| 26.442% | |
| 28.7807% | |
| 24.3377% | |
| 27.9658% | |
| 25.3687% | |
| 8.2802% | |
| -4.3631% | |
| -14.5081% | |
| -212.9101% | |
| -164.2234% | |
| -88.2333% | |
| -129.2602% | |
| 9.2105% | |
| -0.7931% | |
| -1,160.5331% | |
| -289.6419% | |
| -424.0271% | |
| -1,756% | |
| 75.4797% | |
| 36.9772% | |
| 59.6449% | |
| 89.5011% | |
| 42.2149% | |
| 46.5334% | |
| 20.9233% | |
| 26.7233% | |
| -22.2702% | |
| -40.0961% | |
| -65.0992% | |
| -98.728% | |
| -82.3194% | |
| -59.8146% | |
| -10.6808% | |
| -30.8998% | |
| -5.6831% | |
| -32.9225% | |
| -39.0261% | |
| -15.2399% | |
| -37.5444% | |
| 2.5395% | |
| -31.1741% | |
| -17.8773% | |
| -40.566% | |
| -90.8317% | |
| -7.3913% | |
| -25.3544% | |
| -9.4111% | |
| -29.4068% | |
| -178.2258% | |
| -217.301% | |
| -103.0826% | |
| 4.065% | |
| 57.0934% | |
| 68.9581% | |
| 65.7082% | |
| 43.8852% | |
| 2.2548% | |
| -10.9717% | |
| -112.69% | |
| -80.1142% | |
| -28.7499% | |
| -8.5548% | |
| 24.5781% | |
| 2.8197% | |
| -32.3636% | |
| -30.9299% | |
| -68.5937% | |
| -78.6987% | |
| -104.0718% | |
| -3,738.5206% | |
| -2,988.6938% | |
| -4,439.8938% | |
| -5,160.9323% | |
| -595.3425% | |
| -388.8122% | |
| -120.1369% |